The characterization of genes that are regulated by IFN-gamma may therefore lead to a better understanding of the mechanisms of the anti-tumor action, as well as the improved utilization of IFN-gamma in the treatment of breast cancer. This evidence concerns the gene IFNG and breast cancer.